S-337395 is an investigational oral antiviral candidate for RSV infection that inhibits the activity of the L protein, which is essential for virus replication. 1,2 Furthermore, this drug has received ...

New York Governor Kathy Hochul has announced inflation refund checks of up to $500 will be paid to eligible New Yorkers.

In the week ending Jan. 10, flu positivity testing was up 20% in California. The report shows moderate RSV activity and low COVID-19 activity in the same period. Norovirus, which causes sudden ...

This includes more than $3 billion in COVID-19 vaccine sales and minimal sales from the RSV vaccine mResvia ... of its investigational in vivo genome-editing candidate, Nexiguran ziclumeran ...

Advances in genetic technology, spurred by the Human Genome Project, have revolutionized cancer risk assessment and management. The guideline underscores the importance of understanding personal ...

Meanwhile, RSV activity is very high in many areas of the U.S., particularly in young children, the agency reported. The levels determined by the CDC measure how frequently a variety of ...

While the number of COVID diagnoses are down compared with this time last year, other illnesses such as the norovirus stomach bug, RSV and whooping cough saw an increase in cases in the last few ...

Bon Secours, Prisma Health and Spartanburg Regional Healthcare System are implementing new visitor restrictions as influenza and respiratory illnesses rise across the country. Bon Secours St ...

Discovered first in the Netherlands in 2001, it's part of the same viral family as RSV, known officially as respiratory syncytial virus. Speaking to the Mirror last week, Dr Andrew Catchpole from ...

Cases of RSV across the country are considered "very high," as rates of other acute respiratory illnesses are also high, the CDC reported Monday. Here's what to know about RSV. Iowa currently is ...

Arexvy has been approved for the prevention of lower respiratory tract disease caused by RSV in all individuals 60 years of age and older and for those aged 50 to 59 years at increased risk.